Table 5 Subgroup analysis of virally supressed individuals (< 200 copies/ml after the initiation on ART)
Parameter | Virally supressed group | Virally supressed group | p value |
|---|---|---|---|
n = 58 | n = 58 | ||
(Naïve) | (ART) | ||
CD4 count (cells/μl) | 292 (152 to 432) | 378 (274 to 633) | < 0.001 |
CD8 count (cells/μl) | 789 (575 to 1044) | 608 (456 to 821) | < 0.001 |
HIV viral load (copies/ml) | 85,320 (11,604 to 298,008) | 20* (20* to 22) | < 0.001 |
HIV viral load (log copies/ml) | 4.9 (4.1 to 5.5) | 1.3* (1.3* to 1.3*) | < 0.001 |
Presence of pericardial effusion | 39 (67%) | 35 (60%) | 0.6 |
Global T2 SIR | 1.5 ± 0.2 | 1.5 ± 0.2 | 0.5 |
Global native T1 mapping (ms) | 1030 ± 48 | 1009 ± 31 | < 0.001 |
Global native T2 mapping (ms) | 48 ± 3 | 48 ± 2 | 0.2 |
Global ECV (%) | 26 ± 4 | 24 ± 3 | 0.006 |
EGE | 4.1 ± 2.8 | 3.7 ± 2.3 | 0.4 |
LGE present | 28 (48%) | 31 (53%) | 0.5 |